The atypical kinase right open reading frame kinase 1 suppresses glioma cell growth through mammalian target of rapamycin inhibition and apoptotic signaling activation
Open Access
- 1 January 2026
- journal article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 15 (1) , 47
Abstract
Background: Gliomas account for the most frequent malignant neoplasms in the central nervous system (CNS). Though there have been developments in therapeutic approaches, the survival rate for most patients remains poor. This research aimed to explore the clinical importance and underlying mechanism of the atypical kinase right open reading frame kinase 1 (RIOK1) in the growth and proliferation of gliomas. Methods: Differential expression analysis and survival analysis were assessed in public glioma datasets. The levels of RIOK1 protein expression in glioma tissues and non-tumor brain tissues were assessed via Western blot and immunohistochemical analysis. Cell Counting Kit-8 (CCK8) and 5-ethynyl-2'-deoxyuridine (EdU) assays were employed to evaluate glioma cell proliferation. Living cell imaging technology was applied to explore the impact of RIOK1 upregulation on glioma cell proliferative capacity under hypoxic conditions. Protein levels of selected protein kinase B/mammalian target of rapamycin (Akt/mTOR) pathway and apoptosis-related signaling members were evaluated using Western blot. Finally, glioma xenograft models were established to investigate the effect of RIOK1 on glioma tumorigenesis in vivo. Results: We observed a significant downregulation of RIOK1 in isocitrate dehydrogenase (IDH) wild-type gliomas relative to IDH mutant-type gliomas. Compared to non-tumor brain tissues, glioma tissues exhibited a significant reduction in RIOK1 expression levels. Furthermore, overexpression of RIOK1 curbed the growth and proliferation of glioma cells, while downregulation of RIOK1 showed the opposite role. Hypoxia induced decreased expression of RIOK1, which was accompanied by elevated expression of hypoxia-inducible factor 1α (HIF-1α). Under hypoxic conditions, overexpression of RIOK1 inhibited the growth of glioma cells as well. Mechanistically, overexpression of RIOK1 diminished mTOR signaling pathway activity while boosting the activity of apoptosis-related signaling. In vivo, RIOK1 downregulation promotes glioma growth. Conclusions: RIOK1 expression is lower in glioma tissues than in non-tumor brain tissues, and is particularly lower in IDH wild-type gliomas. RIOK1 functions as a suppressor of glioma cell survival and proliferation, possibly through mTOR pathway inhibition and apoptotic pathway activation.Keywords
This publication has 42 references indexed in Scilit:
- The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathwayCancer Letters, 2018
- Hypoxic regulation of RIOK3 is a major mechanism for cancer cell invasion and metastasisOncogene, 2014
- A Kinome-Wide RNAi Screen in Drosophila Glia Reveals That the RIO Kinases Mediate Cell Proliferation and Survival through TORC2-Akt Signaling in GlioblastomaPLOS Genetics, 2013
- Atypical protein kinases of the RIO family in archaeaBiochemical Society Transactions, 2013
- Decreased NOS1 Expression in the Anterior Cingulate Cortex in DepressionCerebral Cortex, 2012
- Phosphorylation of Right Open Reading Frame 2 (Rio2) Protein Kinase by Polo-like Kinase 1 Regulates Mitotic ProgressionJournal of Biological Chemistry, 2011
- RIOK3 interacts with caspase-10 and negatively regulates the NF-κB signaling pathwayMolecular and Cellular Biochemistry, 2009
- A Family Portrait of the RIO KinasesJournal of Biological Chemistry, 2005
- Structure and activity of the atypical serine kinase Rio1The FEBS Journal, 2005
- Yeast Rio1p is the founding member of a novel subfamily of protein serine kinases involved in the control of cell cycle progressionMolecular Microbiology, 2002